CRISPR-enabled point-of-care genotyping for APOL1 genetic risk assessment.
Greensmith R, Lape IT, Riella CV, Schubert AJ, Metzger JJ, Dighe AS, Tan X, Hemmer B, Rau J, Wendlinger S, Diederich N, Schütz A, Riella LV, Kaminski MM.
Greensmith R, et al. Among authors: dighe as.
EMBO Mol Med. 2024 Oct;16(10):2619-2637. doi: 10.1038/s44321-024-00126-x. Epub 2024 Sep 13.
EMBO Mol Med. 2024.
PMID: 39271961
Free PMC article.